De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism
- PMID:21237447
- DOI: 10.1016/j.biopsych.2010.11.015
De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism
Abstract
Background: Little is known about the genetics of nonsyndromic intellectual disability (NSID). Recently, we reported de novo truncating mutations in the SYNGAP1 gene of 3 of 94 NSID cases, suggesting that its disruption represents a common cause of autosomal dominant NSID.
Methods: To further explore the involvement of SYNGAP1 in NSID, we sequenced its exons and intronic boundaries in 60 additional sporadic cases of NSID, including 30 patients with autism spectrum disorders (ASD) and 9 with epilepsy, and in 380 control individuals.
Results: We identified de novo out-of-frame deletions in two patients with NSID and mild generalized epilepsy (c.2677delC/p.Q893RfsX184 and c.321_324delGAAG/p. K108VfsX25) and a de novo splicing mutation (c.2294 + 1G>A), which results in the creation of a premature stop codon, in a patient with NSID and autism. No splicing or truncating mutations were found in control subjects.
Conclusions: We provide evidence that truncating mutations in SYNGAP1 are common in NSID and can be also associated with autism.
Copyright © 2011 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.
Similar articles
- Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.Berryer MH, Hamdan FF, Klitten LL, Møller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot-Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G.Berryer MH, et al.Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12.Hum Mutat. 2013.PMID:23161826
- De novo autosomal dominant mutation in SYNGAP1.Cook EH Jr.Cook EH Jr.Autism Res. 2011 Apr;4(2):155-6. doi: 10.1002/aur.198.Autism Res. 2011.PMID:21480541Review.No abstract available.
- De novo STXBP1 mutations in mental retardation and nonsyndromic epilepsy.Hamdan FF, Piton A, Gauthier J, Lortie A, Dubeau F, Dobrzeniecka S, Spiegelman D, Noreau A, Pellerin S, Côté M, Henrion E, Fombonne E, Mottron L, Marineau C, Drapeau P, Lafrenière RG, Lacaille JC, Rouleau GA, Michaud JL.Hamdan FF, et al.Ann Neurol. 2009 Jun;65(6):748-53. doi: 10.1002/ana.21625.Ann Neurol. 2009.PMID:19557857
- A balanced translocation disrupts SYNGAP1 in a patient with intellectual disability, speech impairment, and epilepsy with myoclonic absences (EMA).Klitten LL, Møller RS, Nikanorova M, Silahtaroglu A, Hjalgrim H, Tommerup N.Klitten LL, et al.Epilepsia. 2011 Dec;52(12):e190-3. doi: 10.1111/j.1528-1167.2011.03304.x. Epub 2011 Nov 2.Epilepsia. 2011.PMID:22050443
- Could autism with mental retardation result from digenism and frequent de novo mutations?Moraine C, Bonnet-Brilhault F, Laumonnier F, Gomot M.Moraine C, et al.World J Biol Psychiatry. 2009;10(4 Pt 3):1030-6. doi: 10.1080/15622970802627455.World J Biol Psychiatry. 2009.PMID:19160128Review.
Cited by
- Synaptic Signaling in Learning and Memory.Kennedy MB.Kennedy MB.Cold Spring Harb Perspect Biol. 2013 Dec 30;8(2):a016824. doi: 10.1101/cshperspect.a016824.Cold Spring Harb Perspect Biol. 2013.PMID:24379319Free PMC article.Review.
- MET receptor tyrosine kinase controls dendritic complexity, spine morphogenesis, and glutamatergic synapse maturation in the hippocampus.Qiu S, Lu Z, Levitt P.Qiu S, et al.J Neurosci. 2014 Dec 3;34(49):16166-79. doi: 10.1523/JNEUROSCI.2580-14.2014.J Neurosci. 2014.PMID:25471559Free PMC article.
- SYNGAP1 deficiency disrupts synaptic neoteny in xenotransplanted human cortical neurons in vivo.Vermaercke B, Iwata R, Wierda K, Boubakar L, Rodriguez P, Ditkowska M, Bonin V, Vanderhaeghen P.Vermaercke B, et al.Neuron. 2024 Sep 25;112(18):3058-3068.e8. doi: 10.1016/j.neuron.2024.07.007. Epub 2024 Aug 6.Neuron. 2024.PMID:39111306Free PMC article.
- Developmental and epileptic encephalopathies.Scheffer IE, Zuberi S, Mefford HC, Guerrini R, McTague A.Scheffer IE, et al.Nat Rev Dis Primers. 2024 Sep 5;10(1):61. doi: 10.1038/s41572-024-00546-6.Nat Rev Dis Primers. 2024.PMID:39237642Review.
- Pathogenetics of the RASopathies.Tidyman WE, Rauen KA.Tidyman WE, et al.Hum Mol Genet. 2016 Oct 1;25(R2):R123-R132. doi: 10.1093/hmg/ddw191. Epub 2016 Jul 12.Hum Mol Genet. 2016.PMID:27412009Free PMC article.
Publication types
MeSH terms
Substances
Related information
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases